Pristiq Approval History
- FDA approved: Yes (First approved February 29th, 2008)
- Brand name: Pristiq
- Generic name: desvenlafaxine
- Dosage form: Extended-Release Tablets
- Company: Wyeth Pharmaceuticals
- Treatment for: Depression, Major Depressive Disorder
Pristiq (desvenlafaxine) is a serotonin-norepinephrine reuptake inhibitor (SNRI) approved for the treatment for adult patients with major depressive disorder. Pristiq is also currently under review as a treatment for moderate-to-severe vasomotor symptoms associated with menopause.
Development History and FDA Approval Process for Pristiq
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.